OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dementia with Lewy bodies: an update and outlook
Tiago F. Outeiro, David J. Koss, Daniel Erskine, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 295
Tiago F. Outeiro, David J. Koss, Daniel Erskine, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 295
Showing 1-25 of 295 citing articles:
Research criteria for the diagnosis of prodromal dementia with Lewy bodies
Ian G. McKeith, Tanis J. Ferman, Alan Thomas, et al.
Neurology (2020) Vol. 94, Iss. 17, pp. 743-755
Open Access | Times Cited: 525
Ian G. McKeith, Tanis J. Ferman, Alan Thomas, et al.
Neurology (2020) Vol. 94, Iss. 17, pp. 743-755
Open Access | Times Cited: 525
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Chao Gao, Jingwen Jiang, Yuyan Tan, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 410
Chao Gao, Jingwen Jiang, Yuyan Tan, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 410
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Ana‐Caroline Raulin, Sydney V. Doss, Zachary A. Trottier, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 320
Ana‐Caroline Raulin, Sydney V. Doss, Zachary A. Trottier, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 320
Immune Signaling in Neurodegeneration
Timothy R. Hammond, Samuel E. Marsh, Beth Stevens
Immunity (2019) Vol. 50, Iss. 4, pp. 955-974
Open Access | Times Cited: 281
Timothy R. Hammond, Samuel E. Marsh, Beth Stevens
Immunity (2019) Vol. 50, Iss. 4, pp. 955-974
Open Access | Times Cited: 281
New evidence on the management of Lewy body dementia
John‐Paul Taylor, Ian G. McKeith, David J. Burn, et al.
The Lancet Neurology (2019) Vol. 19, Iss. 2, pp. 157-169
Open Access | Times Cited: 264
John‐Paul Taylor, Ian G. McKeith, David J. Burn, et al.
The Lancet Neurology (2019) Vol. 19, Iss. 2, pp. 157-169
Open Access | Times Cited: 264
Neuropathology and molecular diagnosis of Synucleinopathies
Shunsuke Koga, Hiroaki Sekiya, Naveen Kondru, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 197
Shunsuke Koga, Hiroaki Sekiya, Naveen Kondru, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 197
Tau: Enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies
Che-Wei Chang, Qiang Shao, Lennart Mucke
Science (2021) Vol. 371, Iss. 6532
Open Access | Times Cited: 189
Che-Wei Chang, Qiang Shao, Lennart Mucke
Science (2021) Vol. 371, Iss. 6532
Open Access | Times Cited: 189
TDP-43 Pathology in Alzheimer’s Disease
Axel Meneses, Shunsuke Koga, Justin O’Leary, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 179
Axel Meneses, Shunsuke Koga, Justin O’Leary, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 179
APOE2: protective mechanism and therapeutic implications for Alzheimer’s disease
Zonghua Li, Francis Shue, Na Zhao, et al.
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 169
Zonghua Li, Francis Shue, Na Zhao, et al.
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 169
Adult Hippocampal Neurogenesis in Major Depressive Disorder and Alzheimer’s Disease
Thomas Berger, Hyun Ah Lee, Allan H. Young, et al.
Trends in Molecular Medicine (2020) Vol. 26, Iss. 9, pp. 803-818
Closed Access | Times Cited: 154
Thomas Berger, Hyun Ah Lee, Allan H. Young, et al.
Trends in Molecular Medicine (2020) Vol. 26, Iss. 9, pp. 803-818
Closed Access | Times Cited: 154
APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
Rosalía Fernández‐Calle, Sabine C. Konings, Javier Frontiñán-Rubio, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 140
Rosalía Fernández‐Calle, Sabine C. Konings, Javier Frontiñán-Rubio, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 140
Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson’s disease and dementia with Lewy bodies
Connor Bargar, Wen Wang, Steven A. Gunzler, et al.
Acta Neuropathologica Communications (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 130
Connor Bargar, Wen Wang, Steven A. Gunzler, et al.
Acta Neuropathologica Communications (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 130
α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity
Simona S. Ghanem, Nour K. Majbour, Nishant N. Vaikath, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 15
Open Access | Times Cited: 107
Simona S. Ghanem, Nour K. Majbour, Nishant N. Vaikath, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 15
Open Access | Times Cited: 107
Unveiling the future: Advancements in MRI imaging for neurodegenerative disorders
Lixin Du, Shubham Roy, Pan Wang, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102230-102230
Closed Access | Times Cited: 20
Lixin Du, Shubham Roy, Pan Wang, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102230-102230
Closed Access | Times Cited: 20
Misfolding and aggregation in neurodegenerative diseases: protein quality control machinery as potential therapeutic clearance pathways
Oliwia Koszła, Przemysław Sołek
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 17
Oliwia Koszła, Przemysław Sołek
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 17
Chronic traumatic encephalopathy is a common co-morbidity, but less frequent primary dementia in former soccer and rugby players
Edward B. Lee, Kevin Kinch, Victoria E. Johnson, et al.
Acta Neuropathologica (2019) Vol. 138, Iss. 3, pp. 389-399
Open Access | Times Cited: 122
Edward B. Lee, Kevin Kinch, Victoria E. Johnson, et al.
Acta Neuropathologica (2019) Vol. 138, Iss. 3, pp. 389-399
Open Access | Times Cited: 122
Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases
Danielle Paige Anthony, Manasa Manjunath Hegde, Shreya S. Shetty, et al.
Life Sciences (2021) Vol. 274, pp. 119326-119326
Closed Access | Times Cited: 81
Danielle Paige Anthony, Manasa Manjunath Hegde, Shreya S. Shetty, et al.
Life Sciences (2021) Vol. 274, pp. 119326-119326
Closed Access | Times Cited: 81
Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions
Masahito Yamada, Junji Komatsu, Keiko Nakamura, et al.
Journal of Movement Disorders (2019) Vol. 13, Iss. 1, pp. 1-10
Open Access | Times Cited: 80
Masahito Yamada, Junji Komatsu, Keiko Nakamura, et al.
Journal of Movement Disorders (2019) Vol. 13, Iss. 1, pp. 1-10
Open Access | Times Cited: 80
Immunotherapy for Parkinson’s disease
Aaron Schwab, Mackenzie J. Thurston, Jatin Machhi, et al.
Neurobiology of Disease (2020) Vol. 137, pp. 104760-104760
Open Access | Times Cited: 79
Aaron Schwab, Mackenzie J. Thurston, Jatin Machhi, et al.
Neurobiology of Disease (2020) Vol. 137, pp. 104760-104760
Open Access | Times Cited: 79
VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases
James P. Quinn, Savannah E. Kandigian, Bianca A. Trombetta, et al.
Brain Communications (2021) Vol. 3, Iss. 4
Open Access | Times Cited: 78
James P. Quinn, Savannah E. Kandigian, Bianca A. Trombetta, et al.
Brain Communications (2021) Vol. 3, Iss. 4
Open Access | Times Cited: 78
Anne Stuendl, Tanja Kraus, Madhurima Chatterjee, et al.
Movement Disorders (2021) Vol. 36, Iss. 11, pp. 2508-2518
Open Access | Times Cited: 74
Peripheral inflammation exacerbates α‐synuclein toxicity and neuropathology in Parkinson's models
Pietro La Vitola, Claudia Balducci, Michela Baroni, et al.
Neuropathology and Applied Neurobiology (2020) Vol. 47, Iss. 1, pp. 43-60
Closed Access | Times Cited: 72
Pietro La Vitola, Claudia Balducci, Michela Baroni, et al.
Neuropathology and Applied Neurobiology (2020) Vol. 47, Iss. 1, pp. 43-60
Closed Access | Times Cited: 72
Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson’s disease and their targeted therapeutic approaches: a comprehensive review
Tapan Behl, Gagandeep Kaur, Ovidiu Frăţilă, et al.
Translational Neurodegeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 65
Tapan Behl, Gagandeep Kaur, Ovidiu Frăţilă, et al.
Translational Neurodegeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 65
APOE3 -Jacksonville (V236E) variant reduces self-aggregation and risk of dementia
Chia‐Chen Liu, Melissa E. Murray, Xia Li, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 613
Open Access | Times Cited: 64
Chia‐Chen Liu, Melissa E. Murray, Xia Li, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 613
Open Access | Times Cited: 64
Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related Dementias
Davangere P. Devanand, Seonjoo Lee, Edward D. Huey, et al.
JAMA Psychiatry (2022) Vol. 79, Iss. 4, pp. 359-359
Open Access | Times Cited: 62
Davangere P. Devanand, Seonjoo Lee, Edward D. Huey, et al.
JAMA Psychiatry (2022) Vol. 79, Iss. 4, pp. 359-359
Open Access | Times Cited: 62
